| Literature DB >> 22305426 |
Mingji Li1, Junshu Wang, Yanping Geng, Yikui Li, Qian Wang, Quanfeng Liang, Qingsheng Qi.
Abstract
BACKGROUND: For metabolic engineering, many rate-limiting steps may exist in the pathways of accumulating the target metabolites. Increasing copy number of the desired genes in these pathways is a general method to solve the problem, for example, the employment of the multi-copy plasmid-based expression system. However, this method may bring genetic instability, structural instability and metabolic burden to the host, while integrating of the desired gene into the chromosome may cause inadequate transcription or expression. In this study, we developed a strategy for obtaining gene overexpression by engineering promoter clusters consisted of multiple core-tac-promoters (MCPtacs) in tandem.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22305426 PMCID: PMC3293061 DOI: 10.1186/1475-2859-11-19
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Figure 1Construction outline of the MCP. Fragment 5CPtacs with the flanking sequence was amplified by PCR with p5TG as the template. Fragment 1 was generated by digesting fragment 5CPtacs with BamHI. Fragment 2 was digested from fragment 5CPtacs with BamHI and HindIII. Fragment 3 was linearized from the plasmid p5TG with HindIII. Then, the three fragments were assembled together under the action of T5 exonuclease, Phusion DNA polymerase and Taq DNA ligase in the isothermal process.
Figure 2Determination of the transcription strength of the MCP. (A) The time dependent analysis of the fluorescence/OD600 ratio; (B) The OD600 dependent analysis of the fluorescence/OD600 ratio.
Figure 3Determination of the GFP expression of the MCP. After 16 h cultivation, cells were harvested and lysed completely in isometric PBS. 15 μL supernatant containing GFP was subjected to SDS-PAGE. GFP bands were measured with ImageJ software, and the areas of their corresponding peaks were used to denote the relative GFP amounts. Lane1 Protein Marker, lane2 5874.43, lane3 12432.74, lane4 14813.91, lane5 17585.91, lane6 18039.91, lane7 18487.33, lane8 17334.79, lane9 16975.38, lane10 20819.62, lane11 18758.20, lane12 20396.74.
Figure 4PHB production in the engineered . Glucose consumption and cell growth. Solid circles OD600 of DH5α/ΔpoxB::1TPHB, solid squares OD600 of DH5α/ΔpoxB::5TPHB, open circles glucose consumption of DH5α/ΔpoxB::1TPHB, open squares glucose consumption of DH5α/ΔpoxB::5TPHB.
Effect of the 5CPtacs promoter on the phaCAB genes transcription.
| Genes | |||
|---|---|---|---|
| Relative Expression amount | 8.80 ± 0.39 | 6.62 ± 0.14 | 7.73 ± 0.15 |
Expression levels of phbA, phbB and phbC in DH5α/poxB::5TPHB are relative to that of the control strain DH5α/poxB::1TPHB. The error bars indicate the standard deviation from the mean of the three replicates
Strains and plasmids used in this study
| Strains and plasmids | Relevant properties | Source |
|---|---|---|
| F - Φ80 | Our laboratory | |
| DH5α/ | This work | |
| DH5α/ | This work | |
| DH5α/ | This work | |
| pGreenTIR | [ | |
| pCL1920 | pSC101 replication, SpR | [ |
| pLC | pLC1920-derived, ploylinker | This work |
| pLG | pLC-derived, | This work |
| p1TG | pLG-derived, 1 single copy of the core | This work |
| p2TG | pLG-derived, 2 tandem repeats of the core | This work |
| p3TG | pLG-derived, 3 tandem repeats of the core | This work |
| p4TG | pLG-derived, 4 tandem repeats of the core | This work |
| p5TG | pLG-derived, 5 tandem repeats of the core | This work |
| p6TG | pLG-derived, 6 tandem repeats of the core | This work |
| p7TG | pLG-derived, 7 tandem repeats of the core | This work |
| p8TG | pLG-derived, 8 tandem repeats of the core | This work |
| p9TG | pLG-derived, 9 tandem repeats of the core | This work |
| p10TG | pLG-derived, 10 tandem repeats of the core | This work |
| pCP20 | FLP+, λ | [ |
| pBHR68 | pBluescript II SK--derived, | [ |
| pTKIP | Cloning vector, LP regions, I-SceI restriction sites, AmpR, KmR | [ |
| pTKS/CS | p15A replication, LP regions, I-SceI restriction sites, CmR, TetR | [ |
| pTKRED | pSC101 replication, | [ |
| pTKIP-1TPHB | pTKIP-derived, 1 | This work |
Oligonucleotides used in this study
| oligonucleotides | Sequence |
|---|---|
| 5'-GCCATGCATAGTAAAGGAGAAGAACTT-3' | |
| 5'-GCCCTCGAGCTATTTGTATAGTTCATC-3' | |
| P5 | 5'-CCCGTCTTACTGTCGGGAATTCGTA-3' |
| P5 | 5'-TGCATCTAGTATTTCTCCTCTTTAA-3' |
| 5'-TTAATGCAT GCGACCGGCAAAGGCGCGGCAGCTTCCAC-3' | |
| 5'-ATTCTCGAG TCAGCCCATATGCAGGCCGCCGTTG-3' | |
| 5'-GCAGGGGGATTTGGTTCTCGCATAATCGCCTTATGCCCGA | |
| 5'-GCCACCCTTTTTACCTTAGCCAGTTTGTTTTCGCCAGTTCG | |
| 5'-AACTGAATGGCAAACTGACTGGTA-3' | |
| 5'-TTTCATTTCGCCTTCAGCAGC-3' | |
| 5'-CAAGACCTGGACCTGATGGAG-3' | |
| 5'-GCCGTTCACATTGACCTTGG-3' | |
| 5'-GTGGTGTTCCGCAAGATGAC-3' | |
| 5'-CGACGAGATGTTGACGATGC-3' | |
| 5'-CTGGACTTTGCCGACAC-3' | |
| 5'-CGTAGTTCCACACCAGG-3' | |
| The 5CP | |
Lineate sequence the core-tac-promoter